 |
|
|
| |
Impact of Weight Reduction on Serum Markers and Liver Histology Including
Progression to Cirrhosis in Patients With Nonalcoholic Steatohepatitis and Bridging Fibrosis
|
| |
| |
Reported by Jules Levin
EASL - International Liver Congress™, 19-23 April 2017, Amsterdam, the Netherlands
Vlad Ratziu,1 Arun Sanyal,2 Dawn Torres,3 Holger Hinrichsen,4 Lawrence Serfaty,5 Kiran Bambha,6 Saumya Jayakumar,7 Zachary Goodman,8 Manal F. Abdelmalek,9 Raul Aguilar Schall,10 Catherine Jia,10 Bryan J. McColgan,10 Robert P. Myers,10 G. Mani Subramanian,10 John G. McHutchison,10 Nezam H. Afdhal,11 Stephen A. Harrison12
1Hopital Universitaire Pitie Salpetriere, Paris, France; 2Virginia Commonwealth University, Richmond, VA, USA; 3Walter Reed National Military Medical Center, Bethesda, MD, USA; 4Gastroenterologisch-Hepatologisches Zentrum Kiel, Germany; 5Hopital Saint-Antoine, Paris, France; 6University of Washington, Seattle, WA, USA; 7University of Calgary, Calgary, AB, Canada; 8Inova Fairfax Hospital, Falls Church, VA, USA; 9Duke Clinical Research Institute, Durham, NC, USA; 10Gilead Sciences, Inc., Foster City, CA, USA; 11Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; 12Pinnacle Clinical Research, San Antonio, TX, USA
|
| |
|
|
|
|
|
